Literatur
Devereaux PJ, POISE-2 Investigators (2014) Rationale and design of the PeriOperative ISchemic Evaluation-2 (POISE-2) trial: an international 2 × 2 factorial randomized controlled trial of acetyl-salicylic acid vs. placebo and clonidine vs. placebo in patients undergoing noncardiac surgery. Am Heart J 167:804–809
Devereaux PJ, Mrkobrada M, Sessler DI et al (2014) Aspirin in patients undergoing noncardiac surgery. N Engl J Med 370:1494–1503
Pulmonary Embolism Prevention (PEP) trial Collaborative Group (2000) Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 355:1295–1302
Antithrombotic Trialists‘ (ATT), C, Baigent C, Blackwell L et al (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373:1849–1860
Interessenkonflikt
C. Özcelik gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Özcelik, C. Perioperative Gabe von Acetylsalicylsäure vermindert nicht das Herzinfarktrisiko bei Patienten mit kardiovaskulären Vorerkrankungen. Kardiologe 8, 364–365 (2014). https://doi.org/10.1007/s12181-014-0608-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12181-014-0608-6